We just received data on a new analyst forecast for $APLS. Eliana Merle from Barclays set a price target of 24.0 for APLS.
To track analyst ratings and price targets for $APLS, check out Quiver Quantitative's $APLS forecast page.
Should you buy $APLS?
Some analysts are better than others. To view the past performance of Barclays, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$APLS Price Targets
Multiple analysts have issued price targets for $APLS recently. We have seen 13 analysts offer price targets for $APLS in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Eliana Merle from Barclays set a target price of $24.0 on 01/28/2026
- Tazeen Ahmad from B of A Securities set a target price of $28.0 on 01/21/2026
- Derek Archila from Wells Fargo set a target price of $26.0 on 01/20/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $35.0 on 01/13/2026
- Joseph Stringer from Needham set a target price of $28.0 on 01/13/2026
- Annabel Samimy from Stifel set a target price of $48.0 on 12/19/2025
- Anupam Rama from JP Morgan set a target price of $36.0 on 11/05/2025
$APLS Insider Trading Activity
$APLS insiders have traded $APLS stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $APLS stock by insiders over the last 6 months:
- CEDRIC FRANCOIS (Chief Executive Officer) has made 0 purchases and 5 sales selling 270,560 shares for an estimated $7,332,531.
- TIMOTHY EUGENE SULLIVAN (Chief Financial Officer) has made 0 purchases and 6 sales selling 69,764 shares for an estimated $1,837,125.
- DAVID O. WATSON (General Counsel) has made 0 purchases and 9 sales selling 61,087 shares for an estimated $1,480,646.
- A. SINCLAIR DUNLOP has made 0 purchases and 2 sales selling 62,184 shares for an estimated $1,451,097.
- NUR NICHOLSON (Chief Technical Officer) has made 0 purchases and 3 sales selling 12,546 shares for an estimated $269,827.
- PASCAL DESCHATELETS (Chief Scientific Officer) has made 0 purchases and 3 sales selling 9,114 shares for an estimated $197,537.
- CAROLINE BAUMAL (Chief Medical Officer) has made 0 purchases and 3 sales selling 7,699 shares for an estimated $175,224.
- MARK JEFFREY DELONG (Chief Business & Strat Officer) has made 0 purchases and 3 sales selling 6,485 shares for an estimated $139,268.
- JAMES GEORGE CHOPAS (VP/Chief Accounting Officer) has made 0 purchases and 5 sales selling 4,400 shares for an estimated $98,621.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APLS Hedge Fund Activity
We have seen 151 institutional investors add shares of $APLS stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 8,448,652 shares (-71.0%) from their portfolio in Q3 2025, for an estimated $191,192,994
- MARSHALL WACE, LLP removed 2,308,102 shares (-85.3%) from their portfolio in Q3 2025, for an estimated $52,232,348
- JENNISON ASSOCIATES LLC added 1,686,232 shares (+63.3%) to their portfolio in Q3 2025, for an estimated $38,159,430
- AQR CAPITAL MANAGEMENT LLC removed 1,489,060 shares (-24.9%) from their portfolio in Q3 2025, for an estimated $33,697,427
- UBS GROUP AG removed 1,305,406 shares (-27.6%) from their portfolio in Q3 2025, for an estimated $29,541,337
- POLAR CAPITAL HOLDINGS PLC added 1,298,055 shares (+96.0%) to their portfolio in Q3 2025, for an estimated $29,374,984
- MILLENNIUM MANAGEMENT LLC added 1,141,274 shares (+563.7%) to their portfolio in Q3 2025, for an estimated $25,827,030
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
